To avoid tumor size‐related contribution to survival rates, inhba siRNA was injected every other day from D11 to D17 (Figure 3P), given that most of the pancreas became tumors at D11 in our previous set of experiments (Figure 3B). Here, INHBA is linked to neoplasm.